A Phase I, Randomised, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1386 in Healthy Japanese Young and Elderly Subjects After Oral Multiple Doses.
Phase of Trial: Phase I
Latest Information Update: 02 Oct 2009
At a glance
- Drugs AZD 1386 (Primary)
- Indications Gastro-oesophageal reflux; Pain
- Focus Adverse reactions
- Acronyms JMAD
- 02 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Sep 2008 New trial record.